| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 618,656 | 590,829 | 586,979 | 622,183 | | Cost of Revenue | 356,940 | 322,491 | 342,015 | 674,155 | | | Gross Profit | 261,716 | 268,338 | 244,964 | (51,972) | | | Operating Expenses | | Research Development | 11,252 | 11,945 | 9,778 | 12,405 | | Selling General and Administrative | 109,453 | 115,003 | 111,144 | (112,545) | | Non Recurring | 2,553 | 27,000 | 614 | 18,308 | | Others | 72,100 | 77,157 | 82,367 | 82,959 | | | | Total Operating Expenses | 195,358 | 231,105 | 203,903 | 1,127 | | | | Operating Income or Loss | 66,358 | 37,233 | 41,061 | (53,099) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (135,906) | (97,683) | (24,614) | (134,462) | | Earnings Before Interest And Taxes | (69,548) | (60,450) | 16,447 | (184,472) | | Interest Expense | 78,527 | 95,792 | 65,743 | 61,197 | | Income Before Tax | (148,075) | (156,242) | (49,296) | (245,669) | | Income Tax Expense | 1,115 | 1,114 | 1,115 | 175 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (412,957) | (157,356) | (50,411) | (245,844) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (149,190) | (157,356) | (50,411) | (245,844) | | Preferred Stock And Other Adjustments |
-
|
-
| (186,188) |
-
| | | Net Income Applicable To Common Shares | ($149,190) | ($157,356) | ($236,599) | ($245,844) |
|
0.01% Nasdaq 0.00%
Income Statement
